JACC: CardioOncology March 01, 2020 | Vol. 2 No. 1 – Table of Contents of this issue
ARTICLES IN THIS ISSUE (open access):
- ORIGINAL RESEARCH: Cardiac Adverse Events in EGFR-Mutated Non-Small Cell Lung Cancer Treated With Osimertinib – Kei Kunimasa, Masashi Fujita, et al.
- EDITORIAL COMMENT: Targeting the Cardiotoxicity of Epidermal Growth Factor Receptor Inhibitors – Dipesh Uprety and Aaron S. Mansfield
- Early Detection and Prediction of Anthracycline-Induced Right Ventricular Cardiotoxicity by 3-Dimensional Echocardiography – Rui Zhao, Leilei Cheng, et al.
- EDITORIAL COMMENT: Anthracycline-Induced CardiotoxicityRemembering the Forgotten Ventricle – Jennifer E. Liu
- Longitudinal Changes in Echocardiographic Parameters of Cardiac Function in Pediatric Cancer Survivors – William L. Border, Eric J. Chow, et al.
- EDITORIAL COMMENT: Childhood Cancer SurvivorsScreening Little Hearts for Big Problems – Ming Hui Chen
- Repeated Remote Ischemic Conditioning Reduces Doxorubicin-Induced Cardiotoxicity – Quan He, Andrew N. Redington, et al.
- EDITORIAL COMMENT: Repeated Remote Ischemic Conditioning Protects Against Doxorubicin Cardiotoxicity: Never Too Much of a Good Thing – Derek J. Hausenloy, Jun Hua Chong, et al.
- Plasma Hepatocyte Growth Factor for Diagnosis and Prognosis in Light Chain and Transthyretin Cardiac Amyloidosis – Kathleen W. Zhang, Daniel J. Lenihan, et al.
- EDITORIAL COMMENT: Hepatocyte Growth Factor and Cardiac Amyloidosis – Frederick L. Ruberg and Omar K. Siddiqi
- Cardiovascular Safety of Degarelix Versus Leuprolide for Advanced Prostate Cancer: The PRONOUNCE Trial Study Design – Chiara Melloni, Matthew T. Roe, et al.
- EDITORIAL COMMENT: Addressing Cardiovascular Risk of Prostate Cancer Hormonal Therapy – Charles J. Ryan and Alicia K. Morgans
- STATE-OF-THE-ART REVIEW: Using Behavioral Economics and Technology to Improve Outcomes in Cardio-Oncology – Kimberly J. Waddell, Mitesh S. Patel, et al.
- PRIMERS IN CARDIO-ONCOLOGY: CAR T Cell Therapy–Related Cardiovascular Outcomes and Management: Systemic Disease or Direct Cardiotoxicity? – Arjun K. Ghosh, Claire Roddie, et al.
- EDITORIAL COMMENT: CARTing Away Cardiac Fibrosis – Jonathan A. Epsteinbresbres
- RESEARCH LETTER: Fatigue, Cardiovascular Decline, and Events after Breast Cancer Treatment: Rationale and Design of UPBEAT Study – Jennifer H. Jordan, W. Gregory Hundley, et al.
- CLINICAL CASE CHALLENGES: Heart Failure Associated With the Epidermal Growth Factor Receptor Inhibitor Osimertinib – Andrew J. Piper-Vallillo, Aarti Asnani, et al.
- CLINICAL CASE CHALLENGES: Aortic Stenosis and the Tyrosine Kinase Inhibitor Nilotinib in Chronic Myeloid Leukemia – Miguel Carracedo, Magnus Bäck, et al.
- CLINICAL CASE CHALLENGES: Evidence of Concurrent Light Chain and Transthyretin Cardiac Amyloidosis in 2 Patients – Joseph P. Donnelly, Mazen Hanna, et al.
- CLINICAL CASE CHALLENGES: Metastatic Merkel Cell Carcinoma Resulting in Complete Heart Block – Brenden S. Ingraham, Martha Grogan, et al.
- CLINICAL CASE CHALLENGES: Infiltrative Lymphoma-Associated Bradycardia and Cardiac Conduction Abnormalities – Pritha Subramanyam, Jim W. Cheung, et al.
- INTERNATIONAL PERSPECTIVES: Cardio-Oncology in ChinaWe Are on the Go! – Yuhui Zhang, Jian Zhang, et al.
- LEADERSHIP PAGE: Working Together to Advance Cardio-Oncology in China – Yunlong Xia and Jiwei Liu
- EDITOR’S PAGE: Cardio-Oncology and the Patient–Physician Relationship – Bonnie Ky
- VIEWPOINT: Decades After DiagnosisThe Unrecognized Trauma of Surviving – Susan R. Strong
CATEGORY
Cardio-Oncology in generalYEAR OF PUBLICATION 2020Cancer survivorsAnthracycline cardiotoxicityImmunotherapy cardiotoxicityHormone therapy cardiotoxicityCardiotoxicity of anticancer treatmentsCardiotoxicity and left ventricular dysfunctionCardiotoxicity and myocardial ischaemiaCardiotoxicity in childrenCaso clinicoGeneral
Cardio-Oncology in generalYEAR OF PUBLICATION 2020Cancer survivorsAnthracycline cardiotoxicityImmunotherapy cardiotoxicityHormone therapy cardiotoxicityCardiotoxicity of anticancer treatmentsCardiotoxicity and left ventricular dysfunctionCardiotoxicity and myocardial ischaemiaCardiotoxicity in childrenCaso clinicoGeneral